文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

优化磁流体热疗方案,使用 Mn-Zn 铁氧体磁性流体消除乳腺癌 MCF7 细胞。

Optimization of magnetic fluid hyperthermia protocols for the elimination of breast cancer cells MCF7 using Mn-Zn ferrite ferrofluid.

机构信息

Dr. K C Patel R & D Centre, Charotar University of Science & Technology, CHARUSAT Campus, Changa- 388 421, Anand, India.

P D Patel Institute of Applied Sciences, Charotar University of Science & Technology CHARUSAT Campus, Changa- 388 421, Anand, India.

出版信息

J Mater Sci Mater Med. 2023 Mar 14;34(3):11. doi: 10.1007/s10856-023-06715-5.


DOI:10.1007/s10856-023-06715-5
PMID:36917271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10014775/
Abstract

The present study aimed to optimize magnetic fluid hyperthermia (MFH) protocols by standardizing MF incubation time, hyperthermic duration, magnetic field, and MFH sessions to achieve a better hyperthermic response for the profuse killing of human breast cancer cell cells MCF7. Magnetic nanoparticles and MF were characterized using XRD, VSM, and DLS. Induction heating was performed for 30 min at field strengths of 12.5 and 13.3 kA/m at a fixed frequency of 330 kHz with varying concentrations and incubation duration on MCF7 cells. Single and multiple sessions hyperthermia protocols were used to kill MCF7 cells and the cytotoxicity effect was analyzed using MTT assay. Single and multiple sessions MFH protocols were established to kill breast cancer cells utilizing 0.2 mg/mL MF at 13.3 kA/m field and 330 kHz frequency and maintaining the hyperthermic temperature of 43-45 °C for 30 min. The single session MFH revealed severe toxicity of MF leading to more than 75% of cell death after 24 h of MF incubation. Multiple sessions hyperthermia resulted in more than 90% killing of MCF7 cells after two consequent 3 h MF incubation with 3 h gap. Each 3 h of MF incubation was followed by 30 min of induction heating. Multiple sessions hyperthermia was effective in killing a larger cell population compared to the single session protocol. The results may help in optimizing protocols for the profuse killing of cancer cells of multiple origins, and aid in deciding futuristic in vivo MFH-based therapeutic strategies against breast cancer. Variation in MCF7 cells' viability due to HT, MF, and MF + HT in multiple sessions.

摘要

本研究旨在通过标准化 MF 孵育时间、热疗持续时间、磁场和 MFH 疗程来优化磁流体热疗 (MFH) 方案,以实现更好的热疗反应,从而大量杀死人乳腺癌细胞 MCF7。使用 XRD、VSM 和 DLS 对磁性纳米粒子和 MF 进行了表征。在 330 kHz 的固定频率下,在 12.5 和 13.3 kA/m 的场强下进行感应加热 30 分钟,同时改变 MCF7 细胞的浓度和孵育时间。使用单次和多次疗程 MFH 方案来杀死 MCF7 细胞,并使用 MTT 测定法分析细胞毒性作用。使用 13.3 kA/m 场和 330 kHz 频率的 0.2 mg/mL MF 建立单次和多次疗程 MFH 方案,将热疗温度维持在 43-45°C 30 分钟。单次疗程 MFH 显示 MF 具有严重的毒性,导致 MF 孵育 24 小时后超过 75%的细胞死亡。在两次连续的 3 小时 MF 孵育后,每个 3 小时的 MF 孵育间隔 3 小时,随后进行 30 分钟的感应加热,多次疗程热疗导致 MCF7 细胞的死亡率超过 90%。与单次疗程方案相比,多次疗程热疗更有效地杀死更大的细胞群体。这些结果可能有助于优化用于大量杀死多种来源癌细胞的方案,并有助于决定未来基于 MFH 的治疗策略在乳腺癌中的应用。由于 HT、MF 和 MF+HT 在多次疗程中,MCF7 细胞活力发生变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/2a25fd2363e9/10856_2023_6715_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/2b83e47be7bd/10856_2023_6715_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/91edfb4736f7/10856_2023_6715_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/b3b00de101e5/10856_2023_6715_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/fb1650b2fae0/10856_2023_6715_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/2a5f34e92c10/10856_2023_6715_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/a7838bb149e6/10856_2023_6715_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/bd5eaad7586a/10856_2023_6715_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/b6b89369ebf3/10856_2023_6715_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/fc7e8951b6f0/10856_2023_6715_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/2a25fd2363e9/10856_2023_6715_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/2b83e47be7bd/10856_2023_6715_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/91edfb4736f7/10856_2023_6715_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/b3b00de101e5/10856_2023_6715_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/fb1650b2fae0/10856_2023_6715_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/2a5f34e92c10/10856_2023_6715_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/a7838bb149e6/10856_2023_6715_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/bd5eaad7586a/10856_2023_6715_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/b6b89369ebf3/10856_2023_6715_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/fc7e8951b6f0/10856_2023_6715_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38cf/10014775/2a25fd2363e9/10856_2023_6715_Fig9_HTML.jpg

相似文献

[1]
Optimization of magnetic fluid hyperthermia protocols for the elimination of breast cancer cells MCF7 using Mn-Zn ferrite ferrofluid.

J Mater Sci Mater Med. 2023-3-14

[2]
In vitro hyperthermic effect of magnetic fluid on cervical and breast cancer cells.

Sci Rep. 2020-9-17

[3]
Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.

Int J Hyperthermia. 1997

[4]
Recent advances in nanosized Mn-Zn ferrite magnetic fluid hyperthermia for cancer treatment.

J Nanosci Nanotechnol. 2014-1

[5]
Application of biocompatible and ultrastable superparamagnetic iron(III) oxide nanoparticles doped with magnesium for efficient magnetic fluid hyperthermia in lung cancer cells.

J Mater Chem B. 2023-5-10

[6]
Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro.

Int J Hyperthermia. 1996

[7]
Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.

Prostate. 2005-8-1

[8]
Tailored magnetic nanoparticles for optimizing magnetic fluid hyperthermia.

J Biomed Mater Res A. 2011-12-30

[9]
Magnetic Fluid Hyperthermia as Treatment Option for Pancreatic Cancer Cells and Pancreatic Cancer Organoids.

Int J Nanomedicine. 2021

[10]
Development of handheld induction heaters for magnetic fluid hyperthermia applications andevaluation on ovarian and prostate cancer cell lines.

Biomed Phys Eng Express. 2023-3-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索